Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish Women
NCT ID: NCT04619238
Last Updated: 2020-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
155 participants
OBSERVATIONAL
2017-06-01
2019-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods One hundred fifty-five women with urinary incontinence (UI) aged between 19-82 years underwent urodynamic investigation and completed both KHQ and ICIQ-SF. To evaluate the factor structure and construct the validity of the KHQ and ICIQ, Principal Component Analysis (PCA) using VARIMAX rotation was conducted for all questionnaire items. PCA results were also confirmed by Spearman's correlations between KHQ and ICIQ items. Moreover, the internal consistency of the KHQ and ICIQ was estimated by way of Cronbach's alpha coefficient (α). Statistical analysis was performed using STATISTICA version 13.1 software (StatSoft, Poland), as well as open source R software (version 3.4.4).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no urinary incontinence
patients without UI
King's Health Questionnaire
patients fulfilled questionnaire
the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
stress urinary incontinence
patients with SUI
King's Health Questionnaire
patients fulfilled questionnaire
the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
overactive bladder
patients with OAB
King's Health Questionnaire
patients fulfilled questionnaire
the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
mix urinary incontinence
patients with MUI
King's Health Questionnaire
patients fulfilled questionnaire
the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
Urge
patients with urge incontinence
King's Health Questionnaire
patients fulfilled questionnaire
the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
King's Health Questionnaire
patients fulfilled questionnaire
the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form
patients fulfilled ICIQ-SF questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with symptoms of urinary incontinence
* age 18-82 years
Exclusion Criteria
* inability to understand the study protocol
18 Years
82 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Lublin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katarzyna Skorupska
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tomasz Rechberger, Professor
Role: STUDY_DIRECTOR
Medical University of Lublin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Katarzyna Skorupska
Lublin, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2\2020
Identifier Type: -
Identifier Source: org_study_id